GlassScriptPhysician profile
Namrata Varma
NPI 1679703599
$6,509.81
in general payments reported to CMS, 2019-2025
21 companies · $830 in 2025
The $830 reported for 2025 was more than what 83% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $914 · 2020: $602 · 2021: $766 · 2022: $1,132 · 2023: $1,501 · 2024: $765 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,096.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,096.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $1,748.71 | 2019-2022 | |
| Medtronic, INC. | $1,113.81 | 2021-2024 | Stealthstation S8 Platform, Propel, Sinuva |
| Inspire Medical Systems, INC. | $785.84 | 2022-2025 | Inspire |
| Acclarent, INC | $494.01 | 2023 | Trudi Nav Cable, Relieva Spinplus |
| Glaxosmithkline, LLC. | $456.82 | 2021-2025 | Nucala |
| Genzyme Corporation | $342.40 | 2023-2024 | |
| Medtronic USA, INC. | $293.84 | 2019-2020 | |
| Stryker Corporation | $286.58 | 2019-2022 | |
| Smith+Nephew, INC. | $210.59 | 2023-2025 | Rf20000, Tula, Halo |
| Regeneron Healthcare Solutions, INC. | $196.38 | 2019-2024 | Dupixent |
| Integra Lifesciences Corporation | $163.25 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Lilly USA, LLC | $106.69 | 2025 | Zepbound |
| Optinose US, INC. | $70.83 | 2023-2024 | |
| Livanova USA, INC. | $62.67 | 2022 | |
| Aerin Medical INC. | $41.64 | 2024-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $34.16 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $24.60 | 2022 | |
| Olympus America INC. | $19.97 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.43 | 2019 | |
| Alk-Abello, INC | $19.30 | 2021 | |
| Ambu INC. | $18.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Namrata Varma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.